Angiotensin II Type 2 Receptor Blockade is a novel target for murine osteoarthritic pain
Main Authors: | Von Loga, I, Miotla-Zarebska, J, Wyeth, E, McCarthy, T, Bountra, C, Vincent, T |
---|---|
Format: | Conference item |
Language: | English |
Published: |
Elsevier
2019
|
Similar Items
-
Comparison of LABORAS with static incapacitance testing for assessing spontaneous pain behaviour in surgically-induced murine osteoarthritis
by: von Loga, IS, et al.
Published: (2020) -
Inferiority of LABORAS over incapacitance testing to measure spontaneous murine osteoarthritis pain
by: von Loga, IS, et al.
Published: (2019) -
Comparison of LABORAS with static incapacitance testing for assessing spontaneous pain behaviour in surgically-induced murine osteoarthritis
by: Isabell S. von Loga, et al.
Published: (2020-12-01) -
Active immunisation targeting nerve growth factor attenuates chronic pain behaviour in murine osteoarthritis
by: Von Loga, I, et al.
Published: (2019) -
Vaccination against nerve growth factor is an effective pain treatment in murine osteoarthritis
by: von Loga, IS, et al.
Published: (2018)